Страна: Великобритания
Език: английски
Източник: MHRA (Medicines & Healthcare Products Regulatory Agency)
Xylometazoline hydrochloride
Haleon UK Ltd
R01AA07
Xylometazoline hydrochloride
500microgram/1ml
Nasal drops
Nasal
No Controlled Drug Status
Valid as a prescribable product
BNF: 12020200; GTIN: 5051562013309
2JCTOCEQFG 5VCPFCTF $CTEQFG6[RG $CTEQFG0WODGT /CIPKHKECVKQP $#4%1&'+0(1 $94 /KETQOGVTG 2JCTOCEQFG 5VCPFCTF $CTEQFG6[RG $CTEQFG0WODGT /CIPKHKECVKQP $#4%1&'+0(1 $94 /KETQOGVTG )SHJR 5`VU .YLH[)YP[HPU 6;90=05,)()@+967: 5757] 6MMZL[3P[OVNYHWO` 5( 3LHMSL[ 7 5( ;9) $,3B&+$036BB+$/(21B9HUVLRQ 0DU 9 :[\KPV3VJH[PVU! 5VU7YVK\J[PVU +( (>7 5V! $UWZRUN,QIRUPDWLRQ 3DQHO */(47:5V! 4HU\MHJ[\YPUN :P[L! :P[L*VTWVULU[5V! :P[L*OHUNL*VU[YVS5V! (WWYV]PUN4HYRL[! 7YVK\J[4HYRL[;YHKL5HTL! 4H[LYPHS:WLJ5V! 7YPU[7YVJLZZ! ;LJOUPJHS+YH^PUN5V! )HYJVKL5V! )HY>PK[O 9LK\J[PVU! 7OHYTH *VKL 5V! ;V[HS5\TILYVM*VSV\YZPUJS\KPUN=HYUPZO -VPSZ! ;V[HS:WLJPHS -PUPZOLZ! ? 5V 4PJYV;L_[! W[ W[ W[ )VK`;L_[:PAL! 5( -VYT\SH[PVU*VKL :THSSLZ[;L_[:PAL! 3LHKPUN! /VYPAVU[HS:JHSL! 7YVK\J[PVU *VTWVULU[ ;`WL! ,\YVWL 62000000203012 READ ALL OF THIS LEAFLET CAREFULLY BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. This medicine is available without a prescription. However, you still need to use Otrivine Child Nasal Drops carefully to get the best results from it. – Keep this leaflet. You may need to read it again. – Ask your pharmacist if you need more information or advice. – You must contact a doctor if the symptoms worsen or do not improve after 5 days. – If any of the side effects gets serious, or if you notice any side effect not listed in this leaflet, please tell your doctor or pharmacist. IN THIS LEAFLET: 1. What Otrivine Child Nasal Drops are and what they are used for 2. Before you use Otrivine Child Nasal Drops 3. How to use Otrivine Child Nasal Drops 4. Possible side effects 5. How to store Otrivine Child Nasal Drops 6. Further information 1. WHAT OTRIVINE CHILD NASAL DROPS ARE AND WHAT THEY ARE USED FOR Otrivine Child Nasal Drops are for application in the nose to give relief from: • nasal congestion (blocked nose, including colds) • perennial and allergic rhinitis (r Прочетете целия документ
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Otrivine Child Nasal Drops 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Xylometazoline Hydrochloride 0.05% w/v For excipients see 6.1. 3 PHARMACEUTICAL FORM Nasal drops, solution The product is a clear, colourless solution. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS For the relief of nasal congestion associated with the common cold, perennial and allergic rhinitis (including hay fever), sinusitis. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Adults and elderly: Not applicable. Otrivine Child Nasal Drops are contra-indicated in children under 6 years of age. Children between 6 and 12 years under adult supervision (all indications): 1 or 2 drops, in each nostril up to 2 times a day. Not to be used for more than 5 days without the advice of a doctor. (see warnings and precautions) Parents or carers should seek medical attention if the child’s condition deteriorates during treatment. Not more than 2 doses should be given in any 24 hours. Route of administration: Nasal use Do not exceed the stated dose Keep out of the reach and sight of children. 4.3 CONTRAINDICATIONS Known hypersensitivity to Otrivine or any of the excipients Concomitant use of other sympathomimetic decongestants Cardiovascular disease including hypertension Diabetes mellitus Phaeochromocytoma Prostatic hypertrophy Hyperthyroidism Closed angle glaucoma Monoamine oxidase inhibitors (MAOIs, or within 14 days of stopping treatment, see section 4.5) Beta-blockers – (see section 4.5) Inflammation of the skin and/or mucosa of the nasal vestibule Trans-sphenoidal hypophysectomy or nasal surgery exposing the dura mater Not to be used in children under the age of 6 years Rhinitis sicca or atrophic rhinitis 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE Patients are advised not to take decongestants for more than five consecutive days. Prolonged or excessive use may cause rebound congestion and/or atrophy of the nasal mucosa. Otrivine, like other preparations belonging to the same class of Прочетете целия документ